2022 annual financial data
Fate Therapeutics 2022 Net margin
Fate Therapeutics 2022 net margin with verified reported values.
Direct answer
Net margin was -264.86%.
Operating income was -308,386,000 USD and net income was -255,056,000 USD.
Operating cash flow was -248,208,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 96,300,000 USD
- Operating income
- -308,386,000 USD
- Net income
- -255,056,000 USD
- Operating cash flow
- -248,208,000 USD